---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-049451"
form_type: "8-K"
ticker: "ADIL"
cik: "0001513525"
company_name: "ADIAL PHARMACEUTICALS, INC."
filed_at: "2025-05-30T23:59:59+00:00"
generated_at: "2026-05-20T04:17:22.569771+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Adial Pharmaceuticals receives Nasdaq delisting notice for equity below $2.5M minimum

## Summary
- Stockholders' equity of $2,126,662 as of March 31, 2025, below Nasdaq's $2.5M requirement.
- Company has 45 calendar days (until July 7, 2025) to submit a compliance plan to Nasdaq.
- If plan accepted, Nasdaq may grant up to 180 days extension to regain compliance.
- Failure to regain compliance could lead to delisting; company may request a hearing.

## SEC filing metadata
- accession: 0001213900-25-049451
- form_type: 8-K
- ticker: ADIL
- cik: 0001513525
- company_name: ADIAL PHARMACEUTICALS, INC.
- filed_at: 2025-05-30T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1513525/000121390025049451/0001213900-25-049451-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1513525/000121390025049451/ea0243908-8k_adial.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-049451
- JSON: https://secwatch.observer/filing/0001213900-25-049451.json
- Plain text: https://secwatch.observer/filing/0001213900-25-049451.txt

## Key facts
- Listing & Compliance Notices
  ADIAL PHARMACEUTICALS, INC. received a nasdaq noncompliance notice notice regarding stockholders equity (rules 5550(b)(1)).
  - Exchange: nasdaq
  - Notice: noncompliance notice
  - Deficiency: stockholders equity
  - Rules: 5550(b)(1)
  source text: May 23, 2025, Adial Pharmaceuticals, Inc. (the “Company”), received a letter from The Nasdaq Stock Market (“Nasdaq”) stating that the Company was not in compliance with Nasdaq Listing Rule 5550(b)(1) (the “Rule”) because the stockholders’ equity of the Company of $2,126,662 as of March 31, 2025, as reported in the Company’s Quarterly Report on Form 10-Q filed with the SEC on May 14, 2025, was below the minimum requirement of $2,500,000. As of the date of this Current Report on Form 8-K, the Company does not have a market value of listed securities of $35 million, or net income from continued o
  evidence_url: https://www.sec.gov/Archives/edgar/data/1513525/000121390025049451/0001213900-25-049451-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.